CXCL1/GRO alpha/KC/CINC-1 Antibody [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # AF-453-NAJF669

Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Neutralization, Western Blot
Label
Janelia Fluor 669
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant mouse CXCL1/GRO alpha/KC/CINC-1
Arg20-Lys96
Accession # P12850
Arg20-Lys96
Accession # P12850
Specificity
Detects mouse CXCL1/GRO alpha/KC/CINC-1 in direct ELISAs and Western blots.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for CXCL1/GRO alpha/KC/CINC-1 Antibody [Janelia Fluor® 669]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CXCL1/GRO alpha/KC/CINC-1
Alternate Names
CINC-1, CINC1, GRO alpha, KC, MGSA-alpha
Gene Symbol
CXCL1
Additional CXCL1/GRO alpha/KC/CINC-1 Products
Product Documents for CXCL1/GRO alpha/KC/CINC-1 Antibody [Janelia Fluor® 669]
Product Specific Notices for CXCL1/GRO alpha/KC/CINC-1 Antibody [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...